Through a meta-analysis of neurological exosomes, Zhang X. et al. (2023) discovered that Aβ42, T-tau, and P-tau181 in blood neurological exosomes might be used in AD diagnosis. This evidence concerns the gene MAPT and Alzheimer disease.